Year: 2019

St. Louis, Nov. 18, 2019 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today announced it has entered into a definitive agreement regarding the sale of its Technical Packaging business segment, consisting of Thermoform Engineered Quality LLC (TEQ), Plastique Ltd. and Plastique sp. z o.o. to Sonoco Plastics, Inc. and Sonoco Holdings, Inc., subsidiaries of Sonoco Products Company (NYSE: SON), a global manufacturer of industrial and consumer packaging products headquartered in Hartsville, South Carolina.The Company expects to finalize the transaction upon receipt of certain customary regulatory approvals with expected gross cash proceeds of $187 million subject to typical post-closing adjustments.The divestiture is part of the Company’s strategy to focus on the business units which are core to its long-term...

DENVER, Nov. 18, 2019 (GLOBE NEWSWIRE) — RLH Corporation (NYSE:RLH) announced that it has closed on the sale of its Red Lion Airport Hotel Atlanta for $12.25 million in gross proceeds. The Red Lion Airport Hotel Atlanta was held in a joint venture. RLH Corporation will receive $4.8 million in net proceeds after closing costs and the repayment of property level mortgage.  Net proceeds to RLH will be primarily used to reduce corporate level debt.There are an additional three hotels that are under non-binding contract to be sold. It is the Company’s expectation the hotel sales will be completed by the end of Q1 2020.About RLH CorporationRLH Corporation is an innovative hotel company focused on the franchising of upscale, midscale and economy hotels. The company focuses on maximizing return on invested capital for hotel owners across...

WALTHAM, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Praveen Tipirneni, M.D., president and chief executive officer, is scheduled to present a corporate overview at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019, at 1:20 p.m. GMT, in London.A live webcast of the presentation will be available on the Investors section of Morphic’s website at https://www.morphictx.com. An archived replay will be available on the company’s website for a period of 90 days after the conference.About Morphic TherapeuticMorphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment...

HOUSTON, Nov. 18, 2019 (GLOBE NEWSWIRE) — SAExploration Holdings, Inc. (NASDAQ: SAEX, OTCQB: SXPLW), or SAE, today announced a combined $130 million of new projects in Alaska, Canada and the Middle East.The largest contract is valued at approximately $112 million for onshore data acquisition services to be performed on the North Slope of Alaska. The data acquisition services will be conducted over the next three winter seasons, beginning in Q1 2020. In association with this multi-year project award, SAE has entered into a separate agreement with Geospace Technologies Corporation to purchase 30,000 new state-of-the-art GCL recording channels. The new Geospace channels will primarily be utilized during the aforementioned multi-year contract in Alaska, but are also intended to be utilized in other regions, when available, during the...

HARTSVILLE, S.C., Nov. 18, 2019 (GLOBE NEWSWIRE) — Sonoco (NYSE: SON), one of the most sustainable, diversified global packaging companies, today announced it has signed a definitive agreement to acquire Thermoform Engineered Quality, LLC, and Plastique Holdings, LTD, (together TEQ), a global manufacturer of thermoformed packaging serving healthcare, medical device and consumer markets, from ESCO Technologies, Inc. (NYSE: ESE) for approximately $187 million in cash.TEQ, headquartered in Huntley, Ill., produced sales of $88 million in the fiscal year ended September 30, 2018, and operates three thermoforming and extrusion facilities in the United States along with a thermoforming operation in the United Kingdom, and thermoforming and molded-fiber manufacturing in Poland. Each facility has state-of-the-art cleanroom capabilities,...

NORCROSS, Ga., Nov. 18, 2019 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Eliezer Zomer, Ph.D., Vice President, Discovery Research and Product Development for Galectin Therapeutics, will be presenting at the 3rd Annual Anti-Fibrotic Drug Development (AFDD) Summit, held from Nov 18 – 20, 2019 at Revere Hotel Boston Common in Boston, Massachusetts. Dr. Zomer will present Galectin’s discovery program of its next generation of galectin-3 inhibitors for treating chronic fibrotic diseases as well as other diseases. This work is largely that of Galectin Therapeutics’ majority-owned subsidiary Galectin Sciences, LLC in partnership with SBH Sciences of Natick, Massachusetts.Title: Therapeutics for Chronic Fibrotic DiseasesDate:...

RICHMOND, Va., Nov. 18, 2019 (GLOBE NEWSWIRE) — Kinsale Capital Group, Inc. (NASDAQ:KNSL) today announced that its Board of Directors declared a cash dividend of $0.08 per share of common stock. This dividend is payable on December 12, 2019 to all stockholders of record as of the close of business on November 29, 2019.About Kinsale Capital Group, Inc.Kinsale Capital Group, Inc. is a specialty insurance group headquartered in Richmond, Virginia, focusing on the excess and surplus lines market.ContactKinsale Capital Group, Inc.Bryan PetrucelliSenior Vice President, Chief Financial Officer and Treasurer804-289-1272ir@kinsalecapitalgroup.com

Continues to Produce Strong Organic Growth with Record Third Quarter Revenue of $32.1 Million and Adjusted EBITDA of $8.7 Million2019 & 2020 Expansion Goals Remain Fully Funded with $14.7 Million Cash on Balance Sheet and More than $4 Million of Quarterly Cash Flow from OperationsRecently Added Key Talent with Appointment of New Chief Financial Officer and Chief Integration OfficerTORONTO, Nov. 18, 2019 (GLOBE NEWSWIRE) — Ayr Strategies Inc. (CSE: AYR.A, OTCQX: AYRSF) (“Ayr” or the “Company”), a vertically-integrated cannabis multi-state operator (MSO) with a presence in the western and eastern U.S., is reporting financial results for the three and nine months ended September 30, 2019.Unless otherwise noted, all results are presented in U.S. dollars.Q3 2019 Financial Summary (vs. Normalized Q2 2019i)Total revenue increased...

SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional independent member.“We are pleased to expand the perspective of our Board of Directors with the addition of a proven financial leader with substantial experience in strategic transactions, corporate governance and financial reporting,” said Steven J. Mento, Ph.D., President, Chief Executive Officer and co-founder of Conatus. “Kathy’s demonstrated capabilities across a broad range of life science finance initiatives should prove most helpful to Conatus as we continue with Oppenheimer & Co., Inc., in our review of strategic alternatives.”Kathleen ScottMs. Scott is currently a Managing Director at Hale BioPharma Ventures, and Chief Financial...

FORT COLLINS, Colo., Nov. 18, 2019 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ:WWD) today reported financial results for its fiscal year 2019 and fourth quarter ending September 30, 2019. (All amounts are presented on an as reported (U.S. GAAP) basis unless otherwise indicated. All per share amounts are presented on a fully diluted basis. All comparisons are made to the same period of the prior year unless otherwise stated.)Fourth Quarter Fiscal 2019 OverviewNet sales were $737 million for the fourth quarter of 2019, up 2 percentEarnings per share were $1.03, down from $1.16Adjusted earnings per share1 were $1.22, down from $1.39Fiscal Year 2019 OverviewNet sales were $2.90 billion for fiscal year 2019, an increase of 25 percent compared to the prior year. Organic net sales1, which exclude the L’Orange business acquired in June 2018,...